首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >Clinical Evaluation of the Spermatogenic Activity of the Root Extract of Ashwagandha(Withania somnifera) in Oligospermic Males: A Pilot Study
【2h】

Clinical Evaluation of the Spermatogenic Activity of the Root Extract of Ashwagandha(Withania somnifera) in Oligospermic Males: A Pilot Study

机译:南非醉茄根提取物生精活性的临床评价少精症男性体内的With(Withania somnifera):一项初步研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ashwagandha (Withania somnifera) has been described in traditional Indian Ayurvedic medicine as an aphrodisiac that can be used to treat male sexual dysfunction and infertility. This pilot study was conducted to evaluate the spermatogenic activity of Ashwagandha root extract in oligospermic patients. Forty-six male patients with oligospermia (sperm count < 20 million/mL semen) were enrolled and randomized either to treatment (n = 21) with a full-spectrum root extract of Ashwagandha (675 mg/d in three doses for 90 days) or to placebo (n = 25) in the same protocol. Semen parameters and serum hormone levels were estimated at the end of 90-day treatment. There was a 167% increase in sperm count (9.59 ± 4.37 × 106/mL to 25.61 ± 8.6 × 106/mL; P < 0.0001), 53% increase in semen volume (1.74 ± 0.58 mL to 2.76 ± 0.60 mL; P < 0.0001), and 57% increase in sperm motility (18.62 ± 6.11% to 29.19 ± 6.31%; P < 0.0001) on day 90 from baseline. The improvement in these parameters was minimal in the placebo-treated group. Furthermore, a significantly greater improvement and regulation were observed in serum hormone levels with the Ashwagandha treatment as compared to the placebo. The present study adds to the evidence on the therapeutic value of Ashwagandha (Withania somnifera), as attributed in Ayurveda for the treatment of oligospermia leading to infertility.
机译:在传统的印度阿育吠陀医学中,Ashwagandha(Withania somnifera)被描述为一种壮阳药,可用于治疗男性性功能障碍和不育症。进行了这项初步研究,以评估低精子症患者Ashwagandha根提取物的生精活性。招募了46名男性少精症男性患者(精子计数<2000亿/ mL精液),并随机分配给全剂量的Ashwagandha根提取物(675毫克/天,三剂共90天)治疗(n = 21)。或使用相同协议的安慰剂(n = 25)。在90天治疗结束时评估精液参数和血清激素水平。精子数量增加了167%(9.59±4.37×10 6 / mL至25.61±8.6×10 6 / mL; P <0.0001),增加了53%从基线开始的第90天,精液量(1.74±0.58 mL至2.76±0.60 mL; P <0.0001),以及精子运动度增加57%(18.62±6.11%至29.19±6.31%; P <0.0001)。这些参数的改善在安慰剂治疗组中很小。此外,与安慰剂相比,用Ashwagandha治疗可观察到血清激素水平明显改善和调节。本研究为阿育吠陀中的阿什哈甘达(Withania somnifera)的治疗价值提供了证据,该阿什韦甘达(Athwagandha)用于治疗导致不育的少精症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号